Trial Profile
A 5-year follow-up study of monoprophylaxis with Entecavir or tenofovir monotherapy after hepatitis B immunoglobulin withdrawal
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 11 Jul 2017 New trial record